Your Article Summary
See Latest ArticlesMeasuring the Value of KOL Interactions
PharmExec, 06/25/09
Life science industry marketing executives rely on key opinion leaders (KOLs)—physicians and other stakeholders who have earned credibility with their medical colleagues based on their expertise and scientific stature—to diffuse innovation and disseminate scientific information regarding innovative treatments and new products. Thought leaders are a critical component of a pharmaceutical company's professional marketing and medical strategies. But companies face a real challenge in creating, maintaining, and leveraging those relationships while safely navigating logistical issues and regulatory waters.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/29/09
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09